Kiora Pharmaceuticals Inc. (KPRX:NASDAQ) shot up at $0.48, a gain of 31.9%. On Tue, Jun 07, 2022, KPRX:NASDAQ hit a New 2-Week Intraday High of $0.45. The stock got featured on our News Catalysts scanner on Tue, May 31, 2022 at 05:56 PM in the 'MISCELLANEOUS' category. From Wed, May 25, 2022, the stock recorded 37.50% Up Days and 44.44% Green Days
The stock spiked on Thu, Mar 17, 2022 at $0.98 with a volume of 5M+.
About Kiora Pharmaceuticals Inc. (KPRX:NASDAQ)
Kiora Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. It focuses on developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Heartcore Enterprises Inc. (HTCR:NASDAQ), 114.71%
- India Globalization Capital, Inc. (IGC:NYSEMKT), 93.35%
- Qutoutiao Inc. (QTT:NASDAQ), 71.58%
- VivoPower International PLC (VVPR:NASDAQ), 40%
- The Very Good Food Company Inc. (VGFC:NASDAQ), 38.81%
- Kiora Pharmaceuticals Inc. (KPRX:NASDAQ), 31.87%
- Youdao, Inc. (DAO:NYSE), 30%
- Athersys, Inc. (ATHX:NASDAQ), 28.42%
- Imperial Petroleum Inc. (IMPP:NASDAQ), 27.12%
- MINISO Group Holding Limited American Depositary Shares each representing four Class A (MNSO:NYSE), 26.84%